$16.17
0.23[1.44%]
At close: Apr 26
$16.17
0[0.00%]
After Hours: 4:20PM EDT
Edgewise Therapeutics
(NASDAQ:EWTX)Latest News for Edgewise Therapeutics Stock (NASDAQ:EWTX)
Edgewise Therapeutics Stock (NASDAQ: EWTX)
Categories: All
Tuesday, April 23, 2024
Monday, April 22, 2024
Wednesday, April 17, 2024
Tuesday, April 16, 2024
Tuesday, March 12, 2024
Thursday, March 07, 2024
Wednesday, February 28, 2024
Thursday, February 22, 2024
Wednesday, January 31, 2024
Friday, January 26, 2024
Friday, January 19, 2024
- Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Jan 19, 2024, 1:05PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jan 19, 2024, 12:31PM
- What's Going On With Edgewise Therapeutics Stock?Erica Kollmann - Jan 19, 2024, 11:33AM
- World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On FridayAvi Kapoor - Jan 19, 2024, 10:20AM
- Edgewise Therapeutics shares are trading higher after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.Benzinga Newsdesk - Jan 19, 2024, 9:13AM
- Edgewise Therapeutics Announces Pricing Of $240M Underwritten Offering Of 21,818,182 Shares At $11.00/ShareBenzinga Newsdesk - Jan 19, 2024, 8:41AM
Thursday, January 11, 2024
Tuesday, January 09, 2024
Wednesday, December 27, 2023
Thursday, November 30, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Thursday, October 26, 2023
Friday, October 06, 2023
Tuesday, September 26, 2023
Thursday, September 14, 2023
Wednesday, August 16, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Friday, June 30, 2023
Wednesday, June 28, 2023
Tuesday, June 27, 2023
- Analyst Ratings for Edgewise TherapeuticsBenzinga Insights - Jun 27, 2023, 2:00PM
- Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jun 27, 2023, 1:56PM
- Edgewise Therapeutics shares are trading higher after the company announced 12-month topline results from the ongoing ARCH study of EDG-5506 in adults with Becker Muscular Dystrophy.Benzinga Newsdesk - Jun 27, 2023, 12:47PM
- Chief Financial Officer at Edgewise Therapeutics Exercises Options Worth $76KBenzinga Insights - Jun 27, 2023, 11:03AM
- CIRCOR International, Enovix, Edgewise Therapeutics And Other Big Stocks Moving Higher On TuesdayLisa Levin - Jun 27, 2023, 10:31AM
- Truist Securities Reiterates Buy on Edgewise Therapeutics, Maintains $25 Price TargetBenzinga Newsdesk - Jun 27, 2023, 8:51AM
- Edgewise Therapeutics Touts Positive Data From Investigational Drug In Form Of Muscular DystrophyVandana Singh - Jun 27, 2023, 7:43AM